BCL10 Antikörper
-
- Target Alle BCL10 Antikörper anzeigen
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCL10 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)
- Produktmerkmale
- Homo sapiens B-cell CLL/lymphoma 10 (BCL10)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human BCL10 (NP_003912) produced in HEK293T cell.
- Klon
- 6A4
- Isotyp
- IgG1
- Top Product
- Discover our top product BCL10 Primärantikörper
-
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-143) antibody
BCL10 Reaktivität: Human WB, FACS, IHC (p) Wirt: Maus Monoclonal 1185CT13-2-1-2 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 4F8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 24-51), (N-Term) antibodyBCL10 Reaktivität: Human, Maus WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB24271 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human WB, IHC, FACS, StM Wirt: Maus Monoclonal BL10-411 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 98-234) antibodyBCL10 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 3C11F4 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human IHC, IF, FACS, StM Wirt: Kaninchen Monoclonal BL10-2988R unconjugated Recombinant Antibody
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Hund WB, IHC, IHC (p) Wirt: Maus Monoclonal 6A8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-233) antibodyBCL10 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus WB, IF, IHC (p), EIA Wirt: Maus Monoclonal 4F8 unconjugated
-
- Applikationshinweise
- WB 1:2000, IF 1:100, FLOW 1:100
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
- Andere Bezeichnung
- BCL10 (BCL10 Produkte)
- Hintergrund
- This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy.
- Molekulargewicht
- 26.1 kDa
- Gen-ID
- 8915
- NCBI Accession
- NM_003921
- HGNC
- 8915
- Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
-
